Scientists identified a driver of aggressive prostate cancer and a potential way to stop drug-resistant tumors forming.

Lyrfigtu (lirafugratinib), a once-daily pill, is for previously treated cholangiocarcinoma with an FGFR2 fusion or ...

Pfizer said the Food and Drug Administration approved Tukysa as a front-line maintenance treatment for people with a form of breast cancer.

Colorectal cancer most often spreads to the liver. When those liver tumors (called liver metastases) can be removed with ...

In today’s Health Headlines, we’re discussing strides made in breast cancer treatments in recent years. Dr. Eric Winer, director of Yale Cancer Center, an internationally ...

No two days of chemotherapy are the same.

As the standards of care for prostate cancer change, new drugs, combination therapies, and trials enter the therapeutic space ...

Lung cancer is still the top cancer killer, but new developments are shifting what the future might hold for patients.